Skip to main content
. 2004 Mar;94(3):406–415. doi: 10.2105/ajph.94.3.406

TABLE 4—

Characteristics of Study Sites in the Multi-Country Evaluation of IMCI

Tanzania Uganda Bangladesh Peru Brazil
Design Pre–post comparison of 2 IMCI and 2 non-IMCI districts Comparison of 10 districts with different levels of IMCI implementation Randomized trial of 10 health facilities with IMCI and 10 without IMCI Comparison of 25 departments with different levels of IMCI implementation Comparison of 32 IMCI and 64 non-IMCI municipalities
Baseline under-5 mortality 160–180 141 96 58 70
Mortality assessment DSS Surveys DSS + survey Vital statistics Surveys
Household coverage surveys 1999 (baseline) 2000 (baseline) 2000 (baseline) Not planned for Phase 1 2004 (planned)
2004 (planned) 2004 (planned) 2004 (planned)
Health facility assessments 2000 (midway) Ongoing rolling sample 2000 (baseline) 1999 (pilot study in selected departments) 2002 (midway)
2004 (planned)
Cost assessments Included in survey tools Included in survey tools Included in survey tools Not included in Phase 1 Included in survey tools
Randomization None None Yes (2001) None None
Type of inference Plausibility Plausibility Probability Plausibility Plausibility
Malaria Yes Yes None Variable None
Partnerships Ifakara Centre, TEHIP, MOH Johns Hopkins, Makerere University, MOH, USAID ICDDR, B, MOH, USAID Instituto del Niño, MOH Ceará University, MOH

Note. IMCI = Integrated Management of Childhood Illness; DSS = Demographic Surveillance System; TEHIP = Tanzania Essential Health Interventions Project; ICDDR, B = International Centre For Diarrhoeal Disease Research, Bangladesh; MOH = ministry of health; USAID = US Agency for International Development.